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A B S T R A C T
Persistent non-infectious uveitis has a significant morbidity, but the extent to which this is accompanied by inflammation driven remodelling of the tissue is unclear.
To address this question, we studied a series of samples selected from two ocular tissue repositories and identified 15 samples with focal infiltration. Eleven of fifteen
contained lymphocytes, both B cells (CD20 positive) and T cells (CD3 positive). In 20% of the samples there was evidence of ectopic lymphoid like structures with
focal aggregations of B cells and T cells, segregated into anatomically different adjacent zones. To investigate inflammation in the tissue, an analysis of 520 immune
relevant transcripts was carried out and 24 genes were differentially upregulated, compared with control tissue. Two of these (CD14 and fibronectin) were increased
in ocular inflammation compared to control immune tissue (tonsil). We demonstrate that in a significant minority of patients, chronic persistent uveitis leads to
dysregulation of ocular immune surveillance, characterized by the development of areas of local ectopic lymphoid like structures, which may be a target for
therapeutic intervention directed at antibody producing cells.
1. Introduction
Chronic persistent intraocular inflammation often damages ocular
structures producing visual impairment. When the uveitis is un-
differentiated, it has been proposed that an ‘uncontrolled, over-
exuberant immune response’ may contribute to tissue damage
(Forrester et al., 2018). Such exuberance could result from heightened
immunosurveillance within the tissue. In animal models of in-
flammatory disease, tissue remodelling and altered im-
munosurveillance have been demonstrated in many circumstances
(Caspi, 2010; Jones et al., 2016). In this paper, we extend a study of
human tissue (Epps et al., 2018) to determine whether, when persistent
changes are present, they are accompanied by differential expression of
inflammatory gene signatures. The changes we identify are relevant in
human uveitis, and provide underpinning support for therapies that
target B cells.
The healthy retina, like the brain, is immune-privileged and subject
to limited immunosurveillance (Shechter et al., 2013), but when uveitis
develops, large numbers of leukocytes are found in the eye. Many
human autoimmune diseases are associated with chronic persistent
accumulation of T and B lymphocytes (Jones et al., 2016; Rao et al.,
2017), observations that have in recent years have been extended to
include immune privileged CNS tissue (Choi et al., 2012; Pikor et al.,
2017). In the most extreme manifestation of this process, the immune
cellular infiltrate becomes organized as ectopic lymphoid-like struc-
tures (ELS) (Jones et al., 2016). It is plausible that persistent intraocular
inflammation might be accompanied by organisation of the immune
cell infiltrate, playing a similar role to that seen in chronic in-
flammatory infiltrate in other organ-specific autoimmune disorders.
Persistence and organisation of the immune cell infiltrate into ELS is
important, because it influences the prognosis of human disease (Choi
et al., 2012; Germain et al., 2015). Understanding whether ELS develop
in human uveitis and, if so, what the mechanisms of formation are, may
open new avenues for clinical assessment and therapy.
ELS (also known as ectopic lymphoid follicles and tertiary lymphoid
organs) are focal aggregations of lymphocytes that develop in non-
lymphoid tissues during a chronic disease processes such as auto-
immunity, neoplasia and transplant rejection (Aloisi and Pujol-Borrell,
2006; Drayton et al., 2006; Howell et al., 2011; Pitzalis et al., 2014).
ELS have features of secondary lymphoid organs, including focal ag-
gregations of B cells and T cells (in adjacent but anatomically distinct
areas of tissue) and follicular dendritic cell networks resembling the
germinal centre-containing lymphoid follicles of secondary lymphoid
organs (SLOs). These structures have many important properties that
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have been described in both experimental and human disease. They are
sites of autoantibody production (Corsiero et al., 2016), whose presence
has been correlated with response to biologic therapy in rheumatoid
arthritis (Canete et al., 2009). They have also been correlated with
clinical prognosis and neurodegeneration in multiple sclerosis (Choi
et al., 2012; Magliozzi et al., 2007), and they have an influence on anti-
tumour immunity (Germain et al., 2015).
In uveitis B cells and plasma cells have been identified within the
human aqueous and vitreous humor and diffuse and focal infiltrates
observed in the uveal tract and retina by immunocytochemistry
(George et al., 1997; Kim et al., 1987; Lubin et al., 1980; Sabates et al.,
1979). ELS have been described in the retina of R161H mice with ex-
perimental uveitis (Kielczewski et al., 2016) and in the iris, ciliary body
and retina of horses with equine recurrent uveitis (Deeg et al., 2002;
Kleinwort et al., 2016), but they have not been specifically reported in
humans. We therefore characterized the immune cell infiltrate in a
series of human uveitis specimens. We show that features of ELS are
present in a minority of these specimens and these features are ac-
companied by the upregulation of immune associated genes including
those related to B cell function.
2. Materials and methods
Eye pathology databases from the Liverpool Ocular Oncology
Biobank (Liverpool, UK; R + D Number: 4116) and Moorfields Biobank
(London, UK. Ref: 10/H0106/57-2015ETR47), were searched with the
ethical approval of the local institutional review boards, using the
keyword uveitis. From 200 formal NHS histopathology reports, made
over a period of 10 years, we identified 15 samples of enucleated or
eviscerated tissue described as having visible lymphocytes within the
uvea or retina on haematoxylin- and eosin-stained (H&E) sections.
These formalin-fixed paraffin-embedded (FFPE) enucleated or evis-
cerated human eyes were obtained. The limited nature of the available
clinical information meant that a prior history of infections could not be
completely excluded. Two 4 μm sections were examined by im-
munohistochemistry (IHC) for CD3+ T cells and CD20+ B cells. If
CD20+ cells were present in the uvea or retina, additional IHC was
performed to identify whether other features of ELS were present using
four further serial sections stained for the lymphoid follicle markers
CD21 (follicular dendritic cells, FDCs), CD23 (follicular B cells, FoB),
BCL6 (B-cell lymphoma 6 protein) and AID (activation-induced cytidine
deaminase). Sections were de-waxed and subjected to heat-induced
epitope retrieval (with low or high pH antigen retrieval solution ac-
cording to manufacturer's technical data sheet for each antibody) using
EnVision FLEX + Target Retrieval solution and PT Link (Dako;
Glostrup, Denmark). Samples were incubated with peroxidase blocking
solution (Dako) for 5 min to block endogenous peroxidase activity
followed by a 30-min incubation with primary antibody (see Table S1).
All primary antibodies were obtained from Dako with the exception of
anti-AID which was obtained from Life Technologies (now Thermo-
Fisher Scientific, Waltham, USA). Signal from primary antibody was
amplified by incubating samples with a species-appropriate linker
molecule for 15 min where indicated in Table S1. Primary antibody
binding was visualised using the appropriate secondary antibody con-
jugated with HRP (Dako) and diaminobenzidine chromogen (Dako). All
sections were counterstained using haematoxylin and sealed under a
coverslip with Depex Polystyrene prior to viewing. IgG isotype control
antibodies or primary antibodies omitted were used for negative con-
trols. Control tissue without evidence of intraocular inflammation was
examined in parallel.
3. Demographic and clinical data
Demographic and clinical data for each patient were obtained from
the limited clinical information supplied to the histopathologist with
each sample and summarised according to IUSG (Deschenes et al.,
2008) (with respect to aetiology of uveitis) and SUN classifications
(Trusko et al., 2013) (with respect to anatomical classification of
uveitis) (Table 1). The demographic data obtained were age at time of
tissue collection and sex. Clinical data specified disease aetiology,
course and duration. The anatomical classification of disease into
anterior, intermediate, posterior or panuveitis categories was made on
the basis of histopathological appearances as well as the limited clinical
information available from the pathologist's report. No other clinical
documents were available.
4. Immunohistochemical characterisation of B cell infiltrate
Following immunostaining, the tissue sections were examined by
light microscopy to classify the predominant pattern of CD20+ B cell
Table 2
Characteristics of CD20 infiltrate.
Subject CD20 + infiltrate Tissue(s) affected Notes
Diffuse Focal ELS like AID positive
P1 + + + + Iris, ciliary body,
choroid
B cell follicles in iris, ciliary body, and choroid; x/y follicles displaying GC markers
P2 + + + – Choroid, sclera B cell follicles in choroid and sclera; x/y follicles displaying GC markers
P3 + + + + Choroid B cell follicles in choroid; x/y follicles displaying GC markers
P4 + + – – Iris, ciliary body,
choroid
Significant CD20 + infiltrate in iris, ciliary body and choroid with focal aggregations of CD20 + cells
but no other features of ELS
P5 + – – – Iris, ciliary body and
choroid
Dense diffuse infiltrate in iris, ciliary body and choroid but no focal aggregations of CD20 + cells or
other features of ELS
P6 + + – – Choroid CD20 + infiltrate present in choroid with focal aggregations of CD20 + cells proximal to focal
aggregations of CD3+ cells but no clear segregation into B and T cell zones
P7 + – – – Iris, choroid Sparse diffuse CD20 + infiltrate in choroid
P8 + – – – Choroid Sparse diffuse CD20 + infiltrate in choroid
P9 + + – – Choroid Small focal CD20 + aggregations in choroid
P10 – – – – N/A No CD20 + infiltrate present
P11 – – – – N/A No CD20 + infiltrate present
P12 – – – – N/A No CD20 + infiltrate present
P13 + + – – Retina, choroid 2 small focal aggregations of CD20 + cells, 1 in retina (appears perivascular) and 1 in choroid
P14 + + – – Choroid 3 small focal aggregations of CD20 + cells in choroid
P15 – – – – N/A
Infiltrate was classified on the basis of CD20 infiltration as diffuse or focal. ELS was defined as: Focal CD20 + aggregations with CD20/CD3 segregation,
CD21 + network(s), CD23 + cells within areas of CD20 + focal aggregation and BCL6+ cells within area of CD20 + aggregation. Within ELS like tissue, focal
aggregates were tested for AID expression.
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infiltration and record the tissue(s) affected (Table 2). If CD20+ cells
were present in either a diffuse or focal infiltrate, further IHC was
performed for CD21, CD23, BCL6 and AID. Samples were then cate-
gorised as having: (i) sparse infiltrate; (ii) diffuse infiltrate; (iii) focal
infiltration; (iv) focal infiltration with CD20/CD3 segregation and
CD23+ cells, CD21 + network(s), and BCL6+ cells within areas of
CD20+ focal aggregation; (v) as (iv) with added AID positive cells (see
Fig. 1).
5. Image analysis
Tissue sections were analysed on a Leica DM1000 light microscope
(Leica Microsystems, Wetzlar, Germany) using Brightfield imaging.
Images were captured using an EVOS XL Cell Imaging System
(ThermoFisher Scientific, Waltham, USA) and prepared in Photoshop
CS6 for publication.
6. Gene expression and statistical analysis
Three samples of RNA were prepared from each specimen and the
quality of RNA was tested using a Nanodrop and Agilent Bioanalyser.
We studied the ocular tissue of patients with ELS (labelled ELS), ocular
tissue with cell infiltrate (labelled INF), ocular tissue negative for cell
infiltrate (designated NEG) from subjects with persistent uveitis and
normal ocular tissue (labelled NOT) obtained post-mortem for donors
with no history of ophthalmic disease. A single sample was prepared
from tonsil (TON).
RNA expression was assessed by Nanostring using the nCounter®
Human Immunology v2 Panel. This profiles 594 genes; 579 im-
munology-related human genes and 15 internal reference controls. Pre-
processing was carried out to exclude genes with low or undetectable
levels of expression from statistical analysis which reduced the set of
genes that we compared to 520.
Analysis was carried out in the R environment (v3.4.3) using a
linear model for gene expression. Unsupervised clustering of the sam-
ples demonstrated that one sample, from a subject with infiltration
negative uveitis, had a gene expression pattern that resembled that of
samples from eyes with ELS and infiltrate. The subject had a diagnosis
of uveitis associated with juvenile idiopathic arthritis (JIA), and this
sample was removed from further analysis because the clinical diag-
nosis and molecular diagnosis were inconsistent. Normalisation of na-
nostring data was carried out in the limma package, using voom im-
plementing cyclic loess (Law et al., 2014). Differential gene expression
was assessed using the limma package (decideTests: significance level:
corrected P < 0.05, false discovery rate< 0.05) (Ritchie et al., 2015),
to compare samples of ocular tissue from patients with infiltration and
ELS with samples from normal ocular tissue plus samples from patients
without infiltrative disease. (Comparison between samples from pa-
tients with ELS and patients with only infiltration did not identify any
significant differences (four samples compared with two samples). This
likely reflects a lack of statistical power with this low number of re-
plicates. Therefore, absolute expression levels were compared as the
geometric mean of nanostring counts in the different sample groups.
7. Results
We examined FFPE specimens from 15 patients with a history of
uveitis that had undergone either evisceration (n = 3) or enucleation
(n = 12) and whose histopathology report included a finding of visible
lymphocytes. The patient age range was 17–77 years (mean 43 years,
median 34 years) and the male to female ratio was 1:3 (Table 1). All
patients had a history of chronic non-infectious uveitis, with the ma-
jority of patients having panuveitis (n = 11) and smaller numbers
having anterior (n = 1), intermediate (n = 1) or posterior (n = 2)
uveitis. Non-infectious uveitis with no known systemic association
(undifferentiated) constituted the greatest part of the case series
(n = 11), with the remainder of the cases being associated with Beh-
çet's disease (n = 2), JIA (n = 1) or systemic granulomatosis with
polyangiitis (n = 1). Although the patient with JIA had no CD20 in-
filtrate, unsupervised clustering of gene expression indicated an in-
flammatory gene signature, and this case was excluded from the ana-
lysis of differential gene expression.
CD3+ T cells and CD20+ B cells were detected together in 11 out of
15 samples (73%): of the 11 samples containing B cells 2 had a sparse
CD20+ infiltration, 1 had a dense diffuse CD20+ infiltrate (patient 5,
supplementary Fig. 1A), and 8 had focal aggregates of CD20+ cells (e.g.
patients 1 and 2, Supplementary Figs. 1C and 1C respectively). Of the 8
samples with focal CD20+ aggregates, 5 also had areas of diffuse
CD20+ infiltrates (e.g. patient 2 represented in Supplementary Fig. 1C).
In all 11 samples where B cells were present, these cells were seen in
the choroid; Fig. 1 shows a representative dense focal CD20+ infiltrate
typical of those found in patients 1 and 3. In 4 of the 11 samples con-
taining B cells, the anterior uvea (iris, ciliary body or both) was also
involved. Only in 1 of the 11 samples with B cell infiltrate were these
cells seen within the retina (patient 13); patient 2 also had a focal ag-
gregation of B cells within the sclera. Table 2 summarises the tissue
distribution of the B cell infiltrate for each patient.
For all samples where a diffuse or focal CD20+ infiltrate was evi-
dent, further immunohistochemistry was performed on serial sections
that were examined for CD21 (identifying follicular dendritic cells),
CD23 (identifying follicular B cells), BCL6 and AID (both of which are
expressed by germinal centre B cells). These markers were not detected
Fig. 1. Ectopic lymphoid-like structures develop in patients with persistent uveitis. Serial sections from two individual eyes are shown (P1; upper panel and P3; lower
panel). Focal aggregates of CD20 + cells encompass areas of CD21, CD23 and BCL6 immunostaining. CD3+ cells are present adjacent to the focal aggregates of
CD20 + cells with, in addition a few CD3+ cells scattered within the area of CD20 + immunostaining. There is an area of AID expression in a section from patient 3.
The location of the lesion from P1 is identified with an arrow in Supplementary Fig. 1A. Where staining is negative, no image is shown.
S.J. Epps, et al. Experimental Eye Research 191 (2020) 107901
4
in any patient that had only a diffuse B-cell infiltrate. Where there was
focal infiltration, positive staining was detected in a subset of patients
and within each eye in only a subset of lesions. Three patients (20% of
the total case series of 15 patients or 27% of the 11 patients with a B cell
infiltrate) had features of ELS within immune cell infiltrate i.e. focal
aggregations of CD20+ cells and CD3+ cells segregated into anatomi-
cally distinct but adjacent zones, with a CD21+ follicular dendritic cell
(FDC) network, CD23+ cells and BCL6 staining in the B cell zone
(Figs. 1 and 2). In two of these (patients 1 and 3), AID was also detected
(Fig. 1), which provides further evidence of local B cell receptor re-
arrangement.
Staining with anti-CD68 to assess the distribution of macrophages
revealed large numbers of CD68+ cells in the ocular tissues (Fig. 3A),
but only small numbers within the lymphoid aggregates resembling ELS
(Fig. 3B). This indicates that these lymphoid aggregates were not
simply non-caseating granulomata (which are a known feature of ocular
inflammation, e.g. in sarcoidosis).
It was evident that within a single eye there was a range of different
types of immune cell infiltrate (Fig. 2). This extended from simple focal
aggregates of lymphocytes, through focal aggregates of lymphocytes
with an FDC network, to focal aggregates of lymphocytes containing an
FDC network and germinal centre markers (BCL6 and/or AID). CD138+
(syndecan-1 positive) plasma cells were also visible in the areas sur-
rounding lymphoid aggregates (Supplementary Fig. 2).
All the eyes with infiltrating B cells (11/15) also contained CD3+
cells. Selected lymphoid aggregates were stained with CD4 and CD8
lymphocyte markers (Fig. 4). Significant numbers of CD4+ and CD8+
cells were present within the lymphoid aggregates and this was the case
whether or not there was evidence of ELS. This is consistent with data
from animal models of autoimmune uveitis that find that T cell in-
filtration with CD4+ and CD8+ cells is an early feature in the devel-
opment of disease (Boldison et al., 2014, 2015).
Differential gene expression of a panel of immune relevant genes
was carried out on mRNA prepared from selected tissues, comparing
those with (INF and ELS) and without infiltration (NOT and NEG). This
identified 32 genes (corrected P < 0.05, false discovery rate< 0.05)
that varied significantly between the two groups. Comparing any tissue
that contained B-cell infiltrate (i.e. INF plus ELS) with normal and non-
infiltrated tissue, identified 16 genes that were upregulated and 16 that
were downregulated. When samples from tissue with ELS only were
compared to tissue without infiltrate, 31 genes were identified (16
upregulated and 15 downregulated). When these genes were assessed in
unsupervised clustering of all the samples, control and diseased tissue
were clearly segregated, although ELS and inflamed tissues were not
(Fig. 5). The genes also clustered into distinct groups with different
patterns of expression. We did not identify any genes differentially
expressed when we compared inflamed tissue and tissue from patients
with ELS. This is likely to be due to (a) insufficient power because of the
small sample size and (b) that we were studying whole tissue not just
the ELS themselves.
As anticipated from the histology, and expected because we used a
curated human immunology gene panel, genes that were significantly
upregulated in tissue from patients with infiltrate compared with con-
trol samples were predominantly associated with the immune response.
Nineteen genes were upregulated compared with control (NEG plus
NOT) samples. Thirteen were identified both in ELS alone and ELS plus
INF samples, and 6 identified in one or other of the two comparisons.
These are summarised in Table 3 and shown as a reference with the
level of expression of the same genes measured in a single tonsil sample.
Upregulation in this set of genes was on average 20-fold greater in the
inflamed tissue compared with the controls. The genes represent a
broad cross-section of different immune functions, including genes as-
sociated with antibody generation, T cell activation and signalling, in-
nate immunity and chemokine signalling. It was also found that there
was significant upregulation of the cell matrix protein fibronectin. For
the genes, that were found to be differentially expressed in inflamed
ocular tissue, their level of expression in ocular tissue was generally
lower than that measured in the tonsil (Table 3). The exceptions were
Fig. 2. ELS development in a single eye is asynchronous. Serial sections from patient P2 were examined for features of ELS. Positive staining in a representative
selection of lesions is shown. The full range of B cell markers were only present in a minority of cell aggregates. Where staining is negative, no image is shown. The
images within the lowest panel are taken from the lesion marked with an arrow in Supplementary Fig. 1C.
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CD14 and fibronectin, which were upregulated in samples from per-
sistently inflamed eyes, but not expressed at high levels in tonsillar
tissue.
The fold-changes of the downregulated genes were small, which
may represent an insensitivity to changes from an already low baseline,
and these associations were not tabulated further.
8. Discussion
Non-infectious uveitis is most often an autoimmune or autoin-
flammatory disorder (Lee et al., 2014) and has been modelled in many
experimental animal systems, most prominently in rodents. Animal
models of autoimmune uveitis fall into two distinct groups (Caspi,
2010): firstly, those where uveitis is induced by injection of a retinal
protein with an adjuvant resulting in a CD4+ T lymphocyte-mediated
intraocular inflammation; and secondly, those in which uveitis arises
spontaneously such as the R161H model, where mice are transgenic for
a T cell receptor specific for the retinal antigen interphotoreceptor re-
tinoid binding protein (Horai et al., 2015). In both groups of animal
models of uveitis, there is a significant intraocular myeloid cell popu-
lation which effects ocular tissue damage (Forrester et al., 1998).
T cells play a crucial role in the development of uveitis (Lee et al.,
2014), but there is also increasing interest in the role of B lymphocytes
(Smith et al., 2016; Wang et al., 2014). B cells could potentially con-
tribute to the pathophysiology of uveitis in numerous ways that may be
either regulatory or pro-inflammatory. B cells produce antibody and
secretion of antibody (Adamus et al., 2006; Grewal et al., 2014), im-
mune complex formation and subsequent activation of innate effector
mechanisms, such as the complement system, has been implicated in
both experimental and human disease (Marak et al., 1979; Vergani
et al., 1986).
The local integration of immune responses can further condition the
course of disease. Ultimately this can lead to the formation of ELS, focal
aggregations of lymphocytes that develop in non-lymphoid tissues in
response to chronic disease processes such as autoimmunity,
Fig. 3. Macrophages are widely distributed in chronic lesions. IHC staining of
P1 to detect CD68 demonstrates a diffuse infiltration, dense in places (A). These
cells are sparse in regions of lymphoid aggregation (oval area with dashed
margin) and do not have features of granulomata (B).
Fig. 4. Lymphocytes of different phenotypes are present in chronic lesions. IHC
staining of P1, to identify the phenotype of CD3 positive lymphocytes, confirms
that both CD4 positive and CD8 positive cells are present in significant num-
bers.
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inflammation, infection, neoplasia and transplant rejection (Drayton
et al., 2006; Jones et al., 2016). ELS have similarities to secondary
lymphoid organs including focal aggregations of B cells and T cells (in
adjacent but anatomically distinct areas of tissue) and follicular den-
dritic cell networks, resembling the germinal centre-containing lym-
phoid follicles of SLOs. These structures have been reported to have
many important properties in relation to both experimental and human
disease, including being sites of auto-antibody production (Humby
et al., 2009; Pitzalis et al., 2014). They have not been specifically re-
ported in human uveitis, although diffuse and focal B cell and plasma
cell infiltrates have been seen within the human aqueous and vitreous
humor and the uveoretina on immunoprofiling (George et al., 1997;
Kim et al., 1987; Lubin et al., 1980; Sabates et al., 1979).
This study has several limitations. Chorioretinal biopsy is only
performed rarely and predominantly to diagnose neoplasia, so ob-
taining informative specimens was difficult. The samples examined in
this study came from patients with severe and persistent disease, and
experience indicates that the commonest reason for enucleation/evis-
ceration would have been for intractable pain, although this was not
always indicated in the pathology reports. We were therefore restricted
to a small number of subjects, using tissue that was not obtained at
different stages of disease and with very little clinical information.
Tissue was likely not taken on the basis of inflammation, but on the
basis of pain related to other complications. But because the develop-
ment of ELS are associated with poor prognosis in multiple sclerosis
(Choi et al., 2012), it remained important to investigate whether similar
structures could develop in the immune privileged sites of the eye. We
reviewed 200 reports including the word uveitis and studied 15 speci-
mens in detail, finding ELS in 3. The data demonstrate that it is common
for there to be a significant B cell presence within the immune cell
infiltrates within the eye in severe uveitis. It is most often diffuse
(Supplementary Fig. 1A), with or without additional focal features and,
in this series, it is most evident within the uvea (Fig. 1 and
Supplementary Fig. 1). The immune cell infiltrate had features of ELS in
3 out of 15 eyes examined, and 3 out of 11 of eyes with B cell in-
filtration of any kind. ELS in ocular tissue has all the features that are
associated with it in other tissues (Fig. 1) including BCL6 and AID
which are both expressed within germinal centres by B cells undergoing
the germinal centre reaction, somatic hypermutation and class switch
recombination. ELS is therefore a rare complication of severe uveitis,
despite the eye being immune-privileged in the normal state.
The immune cell infiltrate we observed was assessed at a single time
point in a single eye, yet displayed features of ELS at several different
stages of development, from clusters of lymphocytes without FDC net-
works or clear T/B cell segregation, to focal aggregations of T and B
cells segregated into anatomically distinct zones with an FDC network
and the GC markers BCL6 and AID (Fig. 2). This finding is consistent
with the ELS existing as semi-autonomous micro-environments, dy-
namic structures that develop and dissipate independently during the
chronic disease process. The long-term presence of CD4 and CD8 cells
Fig. 5. Genes that were differentially expressed between control ocular tissue (NEG and NOT) and tissue with inflammation (ELS and INF) were grouped by
unsupervised clustering. There is segregation of control versus inflamed eyes. The heatmap illustrates that these genes fall into a number of related groups. Heatmap
was prepared using heatmap.2, part of the gplots package (Warnes et al. 2019).
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(Fig. 4) that always accompanies B cell infiltrate likely relates to both
disease persistence, and to the role that these cells play regulating
immune responses in late disease, as shown in different animal models
(Boldison et al., 2014; Silver et al., 2015).
It was also noted that in human uveitis the uvea is the ocular tissue
predominantly affected by the immune cell infiltrate, with only sparse
lymphocytes visible within the retina (Table 2). This contrasts with the
data from a TCR transgenic animal model (Kielczewski et al., 2016),
where ELS lesions develop within the retina as part of a process of
spontaneous autoimmune uveitis. This discrepancy may relate to dif-
ferences in the choroid in the mouse compared with human uveitis, or
to chronicity of the underlying disease process in the human subjects
compared with the relatively early timepoints at which EAU is usually
studied. The anatomy of the choroid differs between mouse and man, in
that the choroid is much thicker in humans and thus potentially more
conducive to providing a suitable microenvironment for the develop-
ment of ELS. A parallel could be drawn between uveitis and MS, where
ELS have been demonstrated within the meninges rather than the
neural brain parenchyma. Another possibility is that persistent human
uveitis is maintained by reactivity to a different set of ocular auto-
antigens than is studied in animal experiments and that these have a
different anatomical distribution.
Examining inflammatory genes that are selectively upregulated in
ocular tissue, obtained from patients with persistent inflammation,
confirms that these encompass a broad range of immunological func-
tion. One striking finding is the overrepresentation of MS4A1 which is
the gene for CD20, the target of Rituximab. Therapy with this biologic
has been reported in a number of small case studies, where it has been
efficacious (Heiligenhaus et al., 2011; Lasave et al., 2018). Supporting
our observation that the mRNA for CCL18 is increased, CCL18 has been
reported in uveitis in human samples of aqueous humor in 12/30
samples (Abu El-Asrar et al., 2004). This chemokine has been associated
with the accumulation of non-Foxp3 positive T regulatory cells
(Chenivesse et al., 2012). CD14 is co-factor for LPS binding and is ex-
pressed as a GPI-linked protein by monocytes and macrophages. In
uveitis, CD14++CD16+ monocytes are enriched in the circulation of
patients with uveitis, when these patients are treated with glucocorti-
coids (Liu et al., 2015). The high level of CD14 detected may therefore
arise as a result of extensive diffuse infiltration with monocytes
(Fig. 3A). Fibronectin has been highlighted as an important molecule in
recurrent equine uveitis where it has been associated with extracellular
tissue remodelling. Levels of the protein were reduced in the vitreous,
but in tissue sections it could be visualised in a dispersed pattern as-
sociated with a disintegration of the inner limiting membrane (Deeg
et al., 2011). Our finding that fibronectin mRNA remains highly upre-
gulated in the ocular tissue of patients with persistent uveitis suggests
that late in the disease there continues to be significant disruption of
normal extracellular matrix homeostasis, and this may accompany
important changes associated with the stroma (Barone et al., 2016).
In summary, this study of eyes enucleated or eviscerated from pa-
tients with a diagnosis of uveitis demonstrates that when leukocytes are
present in the tissue, T and B cell infiltration is common. ELS formation
is a feature in a minority of cases and this provides a rationale for en-
hanced depth imaging optical coherence tomography in patients with
uveitis as a methodology for a more systematic survey of the anatomical
changes that accompany uveitis (Mrejen and Spaide, 2013), especially
sub-retinal changes. Gene-expression in the affected tissue is consistent
with ongoing active inflammation, and the dynamic nature of this
process is further underlined by the different stages of ELS development
that can be seen, even within the same eye. If this can be coupled with
labelled cell imaging it may provide prognostic information to guide the
use of immunotherapeutic regimens.
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